Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.
第一作者:
Rebecca,Stowe
第一单位:
Birmingham Clinical Trials Unit, College of Medical & Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom. r.l.harrison@bham.ac.uk
作者:
医学主题词
佐剂, 药物(Adjuvants, Pharmaceutic);抗震颤麻痹药(Antiparkinson Agents);临床试验(主题)(Clinical Trials as Topic);残疾鉴定(Disability Evaluation);酶抑制剂(Enzyme Inhibitors);人类(Humans);左旋多巴(Levodopa);帕金森病(Parkinson Disease);治疗结果(Treatment Outcome)
DOI
10.1002/mds.23517
PMID
21370258
发布时间
2025-05-29
基金项目
K-0612/PUK_/Parkinson's UK/United Kingdom
MC_U137686861/MRC_/Medical Research Council/United Kingdom
CRUK_/Cancer Research UK/United Kingdom
- 浏览34
Movement disorders
587-98页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



